1. Home
  2. CRL vs OR Comparison

CRL vs OR Comparison

Compare CRL & OR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • OR
  • Stock Information
  • Founded
  • CRL 1947
  • OR 2014
  • Country
  • CRL United States
  • OR Canada
  • Employees
  • CRL N/A
  • OR N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • OR Precious Metals
  • Sector
  • CRL Health Care
  • OR Basic Materials
  • Exchange
  • CRL Nasdaq
  • OR Nasdaq
  • Market Cap
  • CRL 8.0B
  • OR 7.4B
  • IPO Year
  • CRL 2000
  • OR N/A
  • Fundamental
  • Price
  • CRL $178.73
  • OR $34.19
  • Analyst Decision
  • CRL Buy
  • OR Hold
  • Analyst Count
  • CRL 15
  • OR 4
  • Target Price
  • CRL $190.15
  • OR $36.25
  • AVG Volume (30 Days)
  • CRL 1.1M
  • OR 1.0M
  • Earning Date
  • CRL 11-05-2025
  • OR 11-05-2025
  • Dividend Yield
  • CRL N/A
  • OR 0.62%
  • EPS Growth
  • CRL N/A
  • OR N/A
  • EPS
  • CRL N/A
  • OR 0.78
  • Revenue
  • CRL $4,023,704,000.00
  • OR $243,647,000.00
  • Revenue This Year
  • CRL N/A
  • OR $87.42
  • Revenue Next Year
  • CRL $2.43
  • OR $23.28
  • P/E Ratio
  • CRL N/A
  • OR $43.47
  • Revenue Growth
  • CRL N/A
  • OR 33.28
  • 52 Week Low
  • CRL $91.86
  • OR $17.55
  • 52 Week High
  • CRL $203.01
  • OR $42.25
  • Technical
  • Relative Strength Index (RSI)
  • CRL 58.84
  • OR 55.39
  • Support Level
  • CRL $157.49
  • OR $32.12
  • Resistance Level
  • CRL $172.39
  • OR $34.08
  • Average True Range (ATR)
  • CRL 6.13
  • OR 1.01
  • MACD
  • CRL 0.81
  • OR 0.36
  • Stochastic Oscillator
  • CRL 98.84
  • OR 95.71

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About OR Osisko Gold Royalties Ltd

OR Royalties Inc, formerly Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.

Share on Social Networks: